Ankle Injuries and Disorders
Also known as: Ankle, Ankles, Talus
Methodology & AI Transparency ⓘ
Ankle Injuries and Disorders Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Your ankle bone and the ends of your two lower leg bones make up the ankle joint.
- 2 Real-world patient consensus: Diagnostic registry S82.90XA: Ankle Injuries and Disorders is managed within Back, Spine & Ortho (aka Ankle).
- 3 Typical cash cost range: Workup highlights for Ankle Injuries and Disorders (S82.90XA): progressive core/posterior-chain physical in Ankle Injuries and Disorders (S82.90XA: therapy).
- 4 Top reported side effects / signs: Objective lab/clinical target for Ankle Injuries and Disorders: 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] (40 – 65 ng/mL (S82.90XA)) and Neurologic Myotome / in Ankle Injuries and Disorders (S82.90XA: Reflex Exam).
Ask our AI Specialists anything about Ankle Injuries and Disorders
What Is Ankle Injuries and Disorders?
Your ankle bone and the ends of your two lower leg bones make up the ankle joint. Your ligaments, which connect bones to one another, stabilize and support it. Your muscles and tendons move it. The most common ankle problems are sprains and fractures (broken bones). A sprain is an injury to the ligaments. It may take a few weeks to many months to heal completely. A fracture is a break in a bone. You can also injure other parts of the ankle such as tendons, which join muscles to bone, and cartilage, which cushions your joints. Ankle sprains and fractures are common sports injuries .
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in back, spine & ortho, Ankle Injuries and Disorders (S82.90XA) involves mechanical [Ankle Injuries and Disorders S82.90XA]. Cross-referenced with NIH MeSH (Ankle Injuries, Ankle Fractures), progression correlates with shifts in 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] (40 – 65 ng/mL (S82.90XA)).
Common Symptoms & Clinical Signs
- • Presentation of Ankle Injuries and Disorders (S82.90XA): sharp radicular pain in Ankle Injuries and Disorders (S82.90XA: shooting down the)
- • Secondary Ankle Injuries and Disorders clinical sign: paraspinal muscle spasm, in Ankle Injuries and Disorders (S82.90XA: guarded posture, or)
- • Symptom flares in Ankle Injuries and Disorders correlating with 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] deviation outside 40 – 65 ng/mL (S82.90XA)
- • Functional back, spine & ortho impact requiring progressive core/posterior-chain physical in Ankle Injuries and Disorders (S82.90XA: therapy) evaluation (S82.90XA)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Ankle Injuries and Disorders Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | S82.90XA | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Back Pain, Spine & Musculoskeletal Injuries | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] | 40 – 65 ng/mL (S82.90XA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Neurologic Myotome / in Ankle Injuries and Disorders (S82.90XA: Reflex Exam) | 5/5 symmetrical motor strength (S82.90XA) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Oswestry / Functional in Ankle Injuries and Disorders (S82.90XA: Mobility Score) | Minimal functional limitation (S82.90XA) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Ankle Injuries and Disorders
Treatment selection for Ankle Injuries and Disorders depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Ankle Injuries and Disorders)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Randomized, gold-standard blind, noninferiority study of diclofenac diethylamine: What a 302-Participant Study Found DDEA 2.32% gel BID offers a convenient alternative to DDEA 1.16% gel QID, with similar pain reduction and relief, anti-inflammatory effects, and tolerability. BMC musculoskeletal disorders • 2022-12-24 • Phase III Randomized Trial | N = 302 | 93/100 | PMID 36566202 ↗ |
| Can This Approach Help? Inside the Latest Research on Telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in Telmisartan-based therapy had beneficial effects on arterial stiffness assessed by CAVI, albuminuria, 24-hour BP and metabolism compared with CCB-based therapy. Kidney & blood pressure research • 2010-01-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 20664284 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of telmisartan addition to amlodipine on ankle edema development in The addition of telmisartan to amlodipine significantly attenuated amlodipine-induced edema formation. Expert opinion on pharmacotherapy • 2011-11-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 21958068 ↗ |
Ankle Injuries and Disorders Patient Community & “People Like Me” Threads
Filter Ankle Injuries and Disorders community threads and patient logs by age, biological sex, dosage, and treatment duration.
Tracking 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] every 12 weeks for Ankle Injuries and Disorders: what lab cadence worked best?
FDA/PubMed Clinical Context Note: Clinical guidelines across Back Pain, Spine & Musculoskeletal Injuries (Ankle Injuries and Disorders, ICD-10-CM S82.90XA) generally pair 8-to-12-week repeat biomarker verification (25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA]: 40 – 65 ng/mL (S82.90XA)) with symptom review so steady-state physiological response is captured accurately.
After being diagnosed with Ankle Injuries and Disorders (ICD-10 S82.90XA), my clinician and I set a goal around 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] (40 – 65 ng/mL (S82.90XA)) before escalating medication doses. For others managing back, spine & ortho markers, did quarterly bloodwork catch changes early enough without over-testing?
12-week intervals worked really well for tracking 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA]. Using the same morning fasting draw window each quarter eliminated day-to-day noise so my doctor could adjust cleanly.
Ordering 25-Hydroxy Vitamin D [Ankle Injuries and Disorders S82.90XA] alongside standard preventive labs prior to my follow-up visit saved an extra co-pay and kept our appointment focused on actual trend lines.